Please assess the completion status of the following clinical trial:

Trial Title: Marijuana for HIV-Related Peripheral Neuropathy

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE1/PHASE2
- Number of Arms: None

Eligibility Criteria:
INCLUSION CRITERIA:~* HIV positive.~* Be 18 years or older.~* Diagnosis of HIV-related painful neuropathy.~* Stable antiretroviral therapy or no antiretroviral therapy for at least 8 weeks.~* Prior use of marijuana, at least 6 occasions in their lifetime prior to enrollment.~EXCLUSION CRITERIA: (Not allowed)~* Current use of smoked tobacco products.~* Current methadone treatment.~* Use of smoked marijuana within 30 days of enrollment.~* Diagnosis of diabetes mellitus.~* Currently receiving treatment with corticosteroids.~* Use of INH, dapsone or metronidazole within 8 weeks prior to enrollment.~* Severe heart disease, uncontrolled high blood pressure or lung disease.~* Women who are pregnant or breastfeeding.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).